Concepedia

Hitoshi Ohki

HO

Statistics

Publications

13

Citations

684

H-Index

12

Active since

1991

Affiliations

Daiichi-Sankyo (Japan)(Current)

The University of Tokyo

National Institute of Health Sciences

Daiichi Sankyo (Germany)

Gifu University

Hitoshi Ohki is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

1991–2022

13

Publications

13

Communication: Synthetic Studies on Sialoglycoconjugates 25: Reactivity of Glycosyl Promoters in α-Glycosylation of N-Acetyl-Neuraminic Acid with the Primary and Secondary Hydroxyl Groups in the Suitably Protected Galactose and Lactose Derivatives

Akira Hasegawa, Takao Nagahama, Hitoshi Ohki et al. · Journal of Carbohydrate Chemistry · 1991 · 161 citations

, , +16

A facile, large-scale preparation of the methyl 2-thioglycoside of N-acetylneuraminic acid, and its usefulness for the α-stereoselective synthesis of sialoglycosides

Akira Hasegawa, Hitoshi Ohki, Takao Nagahama et al. · Carbohydrate Research · 1991 · 150 citations

, , +13

Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with in Vivo Antitumor Activity

Junya Kawai, Tadashi Toki, Masahiro Ota et al. · Journal of Medicinal Chemistry · 2019 · 91 citations · Full text

, , +16

Synthetic Studies on Sialoglycoconjugates 41: A Facile Total Synthesis of Ganglioside GM<sub>2</sub>

Akira Hasegawa, Takao Nagahama, Hitoshi Ohki et al. · Journal of Carbohydrate Chemistry · 1992 · 59 citations

, , +17

Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold

Junya Kawai, Masahiro Ota, Hitoshi Ohki et al. · ACS Medicinal Chemistry Letters · 2019 · 49 citations · Full text

, , +8

1–5 of 13